Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1998
08/11/1998US5792785 Method for enhancing pregnancy success in an animal
08/11/1998US5792784 A pseudo-dipeptide product which is histamine or methyl-substituted histamine coupled with a amino acid; used in therapeutical, cosmetological applications and treats vision defect
08/11/1998US5792783 Capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation
08/11/1998US5792782 Treating cryptococcus neoformans
08/11/1998US5792781 Antifungal agents, processes for the preparation thereof, and intermediates
08/11/1998US5792780 Fungicides
08/11/1998US5792777 Biphenyl quinuclidines
08/11/1998US5792772 Enatiomerically pure hydroxylated xanthine compounds
08/11/1998US5792771 For treating tumors, vascular system disorders, diabetes, diabetic retinopathy, rheumatoid arthritis and hemangioma
08/11/1998US5792770 Administering as sedative, tranquilizer, anxiolytic agent
08/11/1998US5792768 Reduced side effects
08/11/1998US5792767 Bicyclic substituted hexahydrobenz e! isoindole alpha-1 adrenergic antagonists
08/11/1998US5792766 Imidazo 1,5-c! quinazolines; a new class of GABA brain receptor ligands
08/11/1998US5792765 Substituted oxazolidinones
08/11/1998US5792764 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
08/11/1998US5792763 Serotonin 5-HT1F agonists
08/11/1998US5792762 Dihydrobenzofluorene compounds, intermediates, compositions and methods
08/11/1998US5792759 Steroids, useful for treatement of heart failure and hypertension
08/11/1998US5792758 Steroid nitrite ester derivatives useful as anti-inflammatory drugs
08/11/1998US5792757 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function
08/11/1998US5792756 Phosphonate nucleotide analog antiviral/antitumor agent for oral drug delivery
08/11/1998US5792753 Topical anticarcinogenic agent
08/11/1998US5792752 Synergistic effect in cancer and leukemic cell growth inhibition when a site 1-selective compound is used in combination with a site 2-selective compound
08/11/1998US5792748 Method for inhibiting neoplastic disease in mammals
08/11/1998US5792648 Isolated, purified polynucleotide sequence encoding polypeptide having specified amino acid sequence
08/11/1998US5792635 Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine
08/11/1998US5792503 Production of isoflavone enriched fractions from soy protein extracts
08/11/1998US5792477 Emulsification of two phases; separation; washing; reducing level of residual solvent
08/11/1998US5792461 Citrus peel extract as 3-hydroxy-3-methylglutaryl CoA(HMG-CoA) reductase inhibitor
08/11/1998US5792455 Anti-idiotypic antibody vaccines
08/11/1998US5792451 Oral drug delivery compositions and methods
08/11/1998US5792449 Compositions containing zinc linoleate for the treatment of skin disorders
08/11/1998CA2113425C Androgens for stimulating the central nervous system and for treating osteoporosis
08/11/1998CA2090234C Method for providing improved analgesic effect
08/11/1998CA2076589C Naphthylethylureas and naphthylethylthioureas, the process for their preparation and pharmaceutical compositions holding same
08/11/1998CA2064160C Use of combinations of gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
08/11/1998CA2029599C Medicaments containing as active substance sulphur-containing carboxylic acids and their use in combating retroviruses
08/11/1998CA2009678C Pyridazinone, oxadiazinone, thiadiazinone and triazinone cardiotonic agents
08/10/1998CA2223008A1 Def1
08/07/1998CA2222984A1 Novel rat
08/06/1998WO1998033938A1 Materials and methods relating to the identification of a polymorphism associated with disease susceptibility
08/06/1998WO1998033929A2 Use of a polypeptide as cell receptor for adenoviruses
08/06/1998WO1998033904A2 An antisense oligonucleotide preparation method
08/06/1998WO1998033896A2 Microorganisms with increased production of clavulanic acid
08/06/1998WO1998033893A2 Ribozymes cleaving epidermal growth factor receptors
08/06/1998WO1998033827A1 Elastomer treatment process to decrease peroxide levels
08/06/1998WO1998033815A1 Amyloid beta protein (globular assembly and uses thereof)
08/06/1998WO1998033802A1 Quinazolinone compounds
08/06/1998WO1998033799A1 Pyrrolopyrazolopyrimidine compound and medicine comprising the same
08/06/1998WO1998033798A2 Pyrido[2,3-d]pyrimidines and 4-amino-pyrimidines as inhibitors of cell proliferation
08/06/1998WO1998033797A1 Pyrrolidine derivatives having phospholipase a2 inhibitory activity
08/06/1998WO1998033795A1 Nanomolar, non-peptide inhibitors of cathepsin d
08/06/1998WO1998033791A1 Dihydropyrimidone derivatives as npy antagonists
08/06/1998WO1998033788A1 Matrix metalloproteinase inhibitors
08/06/1998WO1998033784A1 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4)
08/06/1998WO1998033782A1 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
08/06/1998WO1998033781A1 Method for preventing or treating low renin hypertension by administering an endothelin antagonist
08/06/1998WO1998033780A1 Endothelin antagonists: n-[[2'-[ [(4,5-dimethyl-3-isoxazolyl) amino]sulfonyl]-4-(2-oxazolyl) [1,1'-biphenyl]-2-yl]methyl] -n,3,3-trimethylbutanamide and n-(4,5-dimethyl-3-isoxazolyl) -2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl) methyl] -4'-(2-oxazolyl)[1,1'-biphenyl]-2-sulfonamide and salts thereof
08/06/1998WO1998033779A1 3-amino-1,2-benzoisoxazole derivatives, process for preparation, and use thereof
08/06/1998WO1998033769A1 Substituted derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase ii
08/06/1998WO1998033768A1 Arylsulfonylamino hydroxamic acid derivatives
08/06/1998WO1998033762A1 Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock
08/06/1998WO1998033757A1 Method for preparing substituted anthraquinone and application to the preparation of rheins
08/06/1998WO1998033535A1 System, method and composition for dialysis and shock treatment
08/06/1998WO1998033528A2 Induction of b cell tolerance
08/06/1998WO1998033508A1 Calcareous material
08/06/1998WO1998033506A1 Androgen synthesis inhibitors
08/06/1998WO1998033505A1 Antiviral agents
08/06/1998WO1998033504A1 Treatment of urinary incontinence
08/06/1998WO1998033502A1 Use of 1-[4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyrid-1yl]-2-(6,7-dimethoxynapht-2-yl) ethane for preparing medicines for the treatment of cerebral and neuronal disorders
08/06/1998WO1998033501A1 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
08/06/1998WO1998033500A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting senescence-associated motor impairment
08/06/1998WO1998033499A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for increasing libido in post-menopausal women
08/06/1998WO1998033498A1 Drugs for memory enhancement
08/06/1998WO1998033497A1 Method of enhancing hair growth
08/06/1998WO1998033496A1 Sulphonamide derivatives
08/06/1998WO1998033495A1 Composition of a dietary product that is effective to combat oxidative stress and cell decay
08/06/1998WO1998033494A1 Compositions and methods for prevention and treatment of vascular degenerative diseases
08/06/1998WO1998033493A1 Alcoholic treatment and homeopathic pharmaceutical product
08/06/1998WO1998033492A1 Compounds and methods for therapeutic intervention in preventing diabetic complications
08/06/1998WO1998033491A2 Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase
08/06/1998WO1998033490A2 Use of percaboxylic acids in the control of hairy wart disease
08/06/1998WO1998033486A1 Microparticles and their use in cancer treatment
08/06/1998WO1998033485A1 Method for removing high boiling solvents from drug formulations by vacuum drying
08/06/1998WO1998033482A1 Pain reducing parenteral liposome formulation
08/06/1998WO1998033481A1 Lipid complexes and liposomes of highly insoluble platinum complexes
08/06/1998WO1998033479A1 Haemostatic aerosol composition
08/06/1998WO1998033476A1 Skin preparation
08/06/1998WO1998033475A1 Active synergetic complex and cosmetic and/or pharmaceutical product containing this complex
08/06/1998WO1998033470A2 Substituted perylenequinones for use in photodynamic therapy
08/06/1998WO1998033395A1 Food made from sol of konjak flour
08/06/1998WO1998033379A1 A novel method for treating epidermal or dermal conditions
08/06/1998WO1998026768A3 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating helicobacter pylori infections and the gastroduodenal diseases associated therewith
08/06/1998WO1998024763A3 Immunotherapeutic imides/amides as pde iv and tnf inhibitors
08/06/1998WO1998024436A3 Gel formulations for topical drug delivery
08/06/1998WO1998024411A3 Method for oral administration of buspirone
08/06/1998WO1998022587A3 Pituitary-tumor-transforming-genes, and related products
08/06/1998WO1998021220A3 Saccharide derivatives
08/06/1998WO1998019511A3 Method for the preparation of citalopram
08/06/1998WO1998018440A3 Use of inhibitors of the activity of retinoic acid for treating sensitive skin
1 ... 6622 6623 6624 6625 6626 6627 6628 6629 6630 6631 6632 6633 6634 6635 6636 6637 6638 6639 6640 6641 6642 ... 7860